Aberrant Cathepsin S Induces a Supportive Immune Microenvironment in Follicular Lymphoma

生物 分子生物学 抗原 遗传学
作者
Johannes Adrian Hildebrand,Deepak Bararia,Sebastian Stolz,Sarah Haebe,Stefan Alig,Michael D. Bartoschek,Michael Boesl,Alessandro Pastore,Erik Gaitzsch,Michael Heide,Vindi Jurinović,Monika Szczepanowski,Wolfram Klapper,Abner Louissaint,Christina Ludwig,Sebastian Bultmann,Heinrich Leonhardt,Sebastian Eustermann,Karl‐Peter Hopfner,Wolfgang Hiddemann,Michael von Bergwelt,Christian Steidl,Robert Kridel,David M. Weinstock,Marc Schmidt‐Supprian,Menyhárt B. Sárosi,Verena Passerini,Josef Mautner,Oliver Weigert
出处
期刊:Blood [American Society of Hematology]
卷期号:134 (Supplement_1): 657-657
标识
DOI:10.1182/blood-2019-122663
摘要

The highly variable clinical course of follicular lymphoma (FL) is determined by the molecular heterogeneity of the tumor cells and complex interactions with the microenvironment. Here, we provide biochemical, structural, functional and clinical evidence that aberrant Cathepsin S (CTSS) activity induces a supportive immune microenvironment in FL. By targeted DNA sequencing of 305 diagnostic FL biopsies, we identified somatic mutations of CTSS in 8% of cases (24/305), mostly clustered at Y132 (19/24) converting Y to D (16/19). A subset of CTSS Y132 mutations (N=5) occurred at lower variant allele frequencies (5-10%), indicating subclonality. Another 13% of FL had CTSS amplifications (37/286). CTSS Y132 mutations and CTSS amplifications were mutually exclusive. In a cohort of 51 FL, CTSS amplifications were associated with higher CTSS expression (P=0.05). Of note, a subset of FL without CTSS amplifications also had higher CTSS expression, suggesting additional mechanisms of transcriptional dysregulation. CTSS is a cysteine protease that is highly expressed in endolysosomes of antigen presenting cells and malignant B-cells. CTSS is involved in proteolytical processing of antigenic peptides for presentation on MHC-II to be recognized by antigen specific CD4+ T-cells. CTSS is synthesized as an inactive zymogen, which is converted to its active form by autocatalytic cleavage of the autoinhibitory propeptide (pro-CTSS). We used CRISPR/Cas9 to introduce CTSS Y132D into Karpas422, a B-cell lymphoma cell line that harbors the FL hallmark translocation t(14;18). Single-cell derived Y132D mutant clones showed >3-fold higher ratios of active CTSS to pro-CTSS (N=4, P=0.0003). Immunoprecipitated CTSS Y132D had >3-fold higher in vitro substrate cleavage activity compared to CTSS wild type (WT) (N=6, P=0.001). We purified pro-CTSS WT and Y132D and assayed their in vitro autocatalytic cleavage over time. The time required to convert 50% of pro-CTSS decreased from 17 minutes for WT to 11 minutes for Y132D (N=3, P=0.04). In contrast, purified active CTSS WT and Y132 had similar in vitro cleavage activities. Molecular dynamics simulations showed that the Y132D mutation shortens the distances by ~2Å between the catalytic triad of active CTSS (C139, H278, N298) and a stretch of amino acids from the proform (L80, G81, D82, S94), which may facilitate intramolecular cleavage. By mass spectrometry we could indeed detect novel intermediate-sized CTSS fragments. Thus, Y132D does not increase the activity of the mature enzyme but is a gain-of-function mutation by accelerating the conversion from pro-CTSS to catalytically active CTSS. CD74 (invariant chain) is a physiologic CTSS substrate that plays critical roles in the assembly, trafficking and stabilization of peptide-free MHC-II. CTSS cleaves CD74, thereby allowing binding and presentation of antigens on MHC-II to antigen specific CD4+ T-cells. We could show that CTSS Y132D enhanced CD74 cleavage in Karpas422 cells. We then tested the impact of CTSS on antigen specific CD4+ T-cell activation in co-culture assays. CTSS knock-out lymphoma cells were broadly incapable of activating CD4+ T-cells. Overexpression of CTSS WT activated CD4+ T-cells more efficiently compared to empty vector control. CTSS Y132 had the highest capacity to stimulate antigen specific CD4+ T-cell responses. Furthermore, in primary FL biopsies (N=51) CTSS Y132 mutations had gene expression profiles linked with antigen-processing and chemokine perturbation, including CXCL13, a B-cell chemoattractant produced by activated CD4+ T-follicular helper cells. Lastly, we aimed to correlate CTSS aberrations with clinical outcome in patients who received standard immunochemotherapy (R-CHOP) for advanced FL (N=51 with available CTSS mutation and gene expression data). Compared to all other patients (N=34), patients with CTSS Y132 mutations or CTSS overexpression (N=17) had longer failure free survival (P=0.012) and overall survival (P=0.041). In summary, we propose that aberrant CTSS activity - even if only present in a FL subclone - can elicit a CD4+ T-cell driven tumor-promoting immune response, which could be amplified within the microenvironment via pro-inflammatory and chemotactic cytokines and substantially impact the biology and clinical course of the disease. Thus, aberrant CTSS activity is a promising biomarker and therapeutic target in FL and potentially also other tumors. Disclosures Klapper: Roche, Takeda, Amgen, Regeneron: Honoraria, Research Funding. Hiddemann:Bayer: Research Funding; Roche: Consultancy, Honoraria, Research Funding; Gilead: Consultancy, Honoraria; Janssen: Consultancy, Honoraria, Research Funding; Celgene: Consultancy, Honoraria; Vector Therapeutics: Consultancy, Honoraria. Steidl:Juno Therapeutics: Consultancy; Bristol-Myers Squibb: Research Funding; Nanostring: Patents & Royalties: Filed patent on behalf of BC Cancer; Roche: Consultancy; Tioma: Research Funding; Seattle Genetics: Consultancy; Bayer: Consultancy. Kridel:Gilead Sciences: Research Funding. Weinstock:Celgene: Research Funding; Verastem Oncology: Research Funding. Weigert:Novartis: Research Funding; Roche: Research Funding.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CC完成签到 ,获得积分10
3秒前
peiling发布了新的文献求助10
3秒前
科研菜鸟完成签到,获得积分10
3秒前
4秒前
6秒前
zho发布了新的文献求助20
7秒前
豆豆大仙完成签到,获得积分10
7秒前
Handy完成签到,获得积分10
8秒前
小齐发布了新的文献求助10
9秒前
9秒前
9秒前
脑洞疼应助lhy采纳,获得10
9秒前
ss发布了新的文献求助10
11秒前
NexusExplorer应助大气摩托采纳,获得10
12秒前
Yyang完成签到,获得积分10
12秒前
orixero应助peiling采纳,获得10
13秒前
14秒前
hu发布了新的文献求助10
14秒前
15秒前
16秒前
丘比特应助kingz采纳,获得10
16秒前
脑洞疼应助方hh采纳,获得10
17秒前
kekao发布了新的文献求助10
19秒前
19秒前
20秒前
heart发布了新的文献求助10
22秒前
lhy发布了新的文献求助10
22秒前
22秒前
zho发布了新的文献求助20
23秒前
李爱国应助linllll采纳,获得10
24秒前
24秒前
大气摩托发布了新的文献求助10
24秒前
忧郁依霜发布了新的文献求助10
24秒前
小马甲应助耍酷的荆采纳,获得10
24秒前
25秒前
ding应助欢呼的傲旋采纳,获得10
27秒前
Q123ba叭发布了新的文献求助10
27秒前
28秒前
Hello应助BreadCheems采纳,获得10
28秒前
28秒前
高分求助中
The late Devonian Standard Conodont Zonation 2000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 2000
The Lali Section: An Excellent Reference Section for Upper - Devonian in South China 1500
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Very-high-order BVD Schemes Using β-variable THINC Method 830
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 800
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3248438
求助须知:如何正确求助?哪些是违规求助? 2891833
关于积分的说明 8268874
捐赠科研通 2559834
什么是DOI,文献DOI怎么找? 1388717
科研通“疑难数据库(出版商)”最低求助积分说明 650798
邀请新用户注册赠送积分活动 627775